Innovation Pharmaceuticals Inc (IPIX)

[Blue Fin]

NurseAlly, Waiting for proof or what? here is one of the best reasons: Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide scientific rationale and clinical development perspectives for Brilacidin, the Company’s defensin mimetic drug candidate, as a potential novel coronavirus (COVID-19) treatment. Notably, Brilacidin is one of the few drugs targeting COVID-19 that has been tested in humans in Phase 2 clinical trials for other clinical indications, providing an established safety and efficacy profile, thereby potentially enabling it to rapidly help confront the emerging worldwide coronavirus crisis.

Of the top 7 candidates, Only Brilacidin has been tested in human trials. The Grant request was made by the RBL as lead, in conjunction with IP. Lastly Brilacidin was developed as a therapeutic for IBD, Trials so far Include, Ulcerative Colitis, Oral Mucositis, ABSSSSI, and
tests so far on different indications have been 100 % positive. Don't use this as Investment advice just as information.